JUMEIRAH, UAE – Aug. 12, 2017 – PRLog — “Big Data” originally emerged as a term to describe datasets whose size is beyond the ability of traditional databases to capture, store, manage and analyze. However, the scope of the term has significantly expanded over the years. Big Data not only refers to the data itself but also a set of technologies that capture, store, manage and analyze large and variable collections of data, to solve complex problems.
Amid the proliferation of real-time and historical data from sources such as connected devices, web, social media, sensors, log files and transactional applications, Big Data is rapidly gaining traction from a diverse range of vertical sectors. The healthcare and pharmaceutical industry is no exception to this trend, where Big Data has found a host of applications ranging from drug discovery and precision medicine to clinical decision support and population health management.
SNS Research estimates that Big Data investments in the healthcare and pharmaceutical industry will account for nearly $4 Billion in 2017 alone. Led by a plethora of business opportunities for healthcare providers, insurers, payers, government agencies, pharmaceutical companies and other stakeholders, these investments are further expected to grow at a CAGR of more than 15% over the next three years.
To request a report sample: http://www.snsintel.com/big-data-in-the-healthcare–pharm…
The “Big Data in the Healthcare & Pharmaceutical Industry: 2017 – 2030 – Opportunities, Challenges, Strategies & Forecasts” report presents an in-depth assessment of Big Data in the healthcare and pharmaceutical industry including key market drivers, challenges, investment potential, application areas, use cases, future roadmap, value chain, case studies, vendor profiles and strategies. The report also presents market size forecasts for Big Data hardware, software and professional services investments from 2017 through to 2030. The forecasts are segmented for 8 horizontal submarkets, 5 application areas, 36 use cases, 6 regions and 35 countries.
For purchasing details or to request a sample please contact:
View more from SNS Research: http://www.snsintel.com/
About SNS Research
SNS Research is one of the most foremost market intelligence and consulting firms for the worldwide telecommunications industry, with a particular focus on wireless infrastructure and mobile devices. Developed by leading industry analysts our market intelligence and consultancy services provide unique insights to the global telecommunications industry with information ranging from niche details of mobile handset models to tracking to large network infrastructure contracts and cellular network operator metrics. Whether your focus is strategic decision making, service development, investment or marketing, our services will allow you to make optimal decisions with self-assurance.